Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-16

Clinical Trial Update: CP101 for the Treatment of Ulcerative Colitis [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating CP101 for ulcerative colitis is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CP101

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Ulcerative Colitis | Phase 1 | Status: ACTIVE_NOT_RECRUITING